Protalix Biotherapeutics Inc (PLX)
Gross Profit Growth
23.97%
Quarterly · Period ending:
PLX Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported23.97%period ending
Latest reported23.97%period ending
PLX Quarterly Gross Profit YoY % (-80.73% → 23.97%)
Year-over-year change
High-resolution chart · PNG
PLX gross profit growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Gross Profit Growth |
|---|---|
| 23.9681% | |
| 1,432.4884% | |
| -68.5808% | |
| -0.5947% | |
| 143.6038% | |
| 68.6736% | |
| 779.2638% | |
| 75.7887% | |
| -86.1099% | |
| -82.3774% | |
| -73.7942% | |
| -23.3085% | |
| 519.9529% | |
| -35.3% | |
| 15.1639% | |
| -14.8725% | |
| 175.4427% | |
| 53.3333% | |
| -67.7417% | |
| 5.4153% | |
| -81.4661% | |
| -64.0231% | |
| 13.0596% | |
| -28.2622% | |
| -4.3132% | |
| 117.0598% | |
| -40.1415% | |
| 5.9992% | |
| 5,496.6102% | |
| 415.2855% | |
| 2,603.8251% | |
| 613.5616% | |
| -121.1976% | |
| 103.3708% | |
| 609.3023% | |
| 245.9716% | |
| 788.2979% | |
| 413.4615% | |
| 102.5097% | |
| -87.9429% | |
| -91.5392% | |
| -88.9362% | |
| -2,563.2124% | |
| 83.3421% | |
| 2.7752% | |
| -57.4018% | |
| 55.1163% | |
| 7.7314% | |
| -38.0871% | |
| 10.4438% | |
| 61.9469% | |
| -41.3827% | |
| -92.3535% | |
| 24.4601% | |
| -484.3537% | |
| 346.5288% | |
| 3,512.9747% | |
| -53.8874% | |
| 104.9645% | |
| -68.051% | |
| -44.61% | |
| 516.5289% | |
| -85.8174% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -98.9362% | |
| -99.2341% | |
| -80.7314% |